Bhatt, S. et al. The global distribution and burden of dengue. Nature 496, 504–507 (2013).
Article CAS PubMed PubMed Central Google Scholar
Shepard, D. S., Coudeville, L., Halasa, Y. A., Zambrano, B. & Dayan, G. H. Economic impact of dengue illness in the Americas. Am. J. Trop. Med. Hyg. 84, 200–207 (2011).
Article PubMed PubMed Central Google Scholar
Guzman, M. G., Gubler, D. J., Izquierdo, A., Martinez, E. & Halstead, S. B. Dengue infection. Nat. Rev. Dis. Primers 2, 16055 (2016).
Gubler, D. J. Aedes aegypti and Aedes aegypti-borne disease control in the 1990s: top down or bottom up. Charles Franklin Craig lecture. Am. J. Trop. Med. Hyg. 40, 571–578 (1989).
Article CAS PubMed Google Scholar
Iwamura, T., Guzman-Holst, A. & Murray, K. A. Accelerating invasion potential of disease vector Aedes aegypti under climate change. Nat. Commun. 11, 2130 (2020).
Article CAS PubMed PubMed Central Google Scholar
Facts sheet Dengue. World Mosquito Program https://www.worldmosquitoprogram.org/sites/default/files/2020-11/WMP%20dengue_0.pdf (2022).
Anderson, K. B. et al. A shorter time interval between first and second dengue infections is associated with protection from clinical illness in a school-based cohort in Thailand. J. Infect. Dis. 209, 360–368 (2014).
Article CAS PubMed Google Scholar
Montoya, M. et al. Symptomatic versus inapparent outcome in repeat dengue virus infections is influenced by the time interval between infections and study year. PLoS Negl. Trop. Dis. 7, e2357 (2013).
Article PubMed PubMed Central Google Scholar
Guzman, M. G., Alvarez, M. & Halstead, S. B. Secondary infection as a risk factor for dengue hemorrhagic fever/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection. Arch. Virol. 158, 1445–1459 (2013).
Article CAS PubMed Google Scholar
Rajapakse, S., de Silva, N. L., Weeratunga, P., Rodrigo, C. & Fernando, S. D. Prophylactic and therapeutic interventions for bleeding in dengue: a systematic review. Trans. R. Soc. Trop. Med. Hyg. 111, 433–439 (2017).
Article CAS PubMed Google Scholar
Wong, J. G., Thein, T. L., Leo, Y. S., Pang, J. & Lye, D. C. Identifying adult dengue patients at low risk for clinically significant bleeding. PLoS ONE 11, e0148579 (2016).
Article PubMed PubMed Central Google Scholar
Capeding, M. R. et al. Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial. Lancet 384, 1358–1365 (2014).
Article CAS PubMed Google Scholar
Villar, L. et al. Efficacy of a tetravalent dengue vaccine in children in Latin America. N. Engl. J. Med. 372, 113–123 (2015).
World Health, O. Dengue vaccine: WHO position paper, July 2016—recommendations. Vaccine 35, 1200–1201 (2017).
Biswal, S. et al. Efficacy of a tetravalent dengue vaccine in healthy children and adolescents. N. Engl. J. Med. 381, 2009–2019 (2019).
Article CAS PubMed Google Scholar
Biswal, S. et al. Efficacy of a tetravalent dengue vaccine in healthy children aged 4-16 years: a randomised, placebo-controlled, phase 3 trial. Lancet 395, 1423–1433 (2020).
Article CAS PubMed Google Scholar
Takeda’s QDENGA (dengue tetravalent vaccine (live, attenuated)) approved in Indonesia for use regardless of prior dengue exposure. Takeda https://www.takeda.com/newsroom/newsreleases/2022/takedas-qdenga-dengue-tetravalentvaccine-live-attenuated-approved-in-indonesia-for-useregardless-of-prior-dengue-exposure/ (2022).
Thomas, S. J. & Endy, T. P. Current issues in dengue vaccination. Curr. Opin. Infect. Dis. 26, 429–434 (2013).
Article CAS PubMed Google Scholar
Low, J. G., Ooi, E. E. & Vasudevan, S. G. Current status of dengue therapeutics research and development. J. Infect. Dis. 215, S96–S102 (2017).
Article CAS PubMed PubMed Central Google Scholar
Thomas, S. J. Is new dengue vaccine efficacy data a relief or cause for concern? NPJ Vaccines 8, 55 (2023).
Article PubMed PubMed Central Google Scholar
Endy, T. P. et al. A phase 1, open-label assessment of a dengue virus-1 live virus human challenge strain. J. Infect. Dis. 223, 258–267 (2021).
Article CAS PubMed Google Scholar
Mammen, M. P. et al. Evaluation of dengue virus strains for human challenge studies. Vaccine 32, 1488–1494 (2014).
Article CAS PubMed Google Scholar
Sun, W. et al. Experimental dengue virus challenge of human subjects previously vaccinated with live attenuated tetravalent dengue vaccines. J. Infect. Dis. 207, 700–708 (2013).
Article CAS PubMed Google Scholar
Waickman, A. T. et al. Evolution of inflammation and immunity in a dengue virus 1 human infection model. Sci. Transl. Med. 14, eabo5019 (2022).
Article CAS PubMed Google Scholar
Waickman, A. T. et al. Transcriptional and clonal characterization of B cell plasmablast diversity following primary and secondary natural DENV infection. EBioMedicine 54, 102733 (2020).
Article PubMed PubMed Central Google Scholar
Kirkpatrick, B. D. et al. The live attenuated dengue vaccine TV003 elicits complete protection against dengue in a human challenge model. Sci. Transl. Med. 8, 330ra336 (2016).
Hou, R. et al. The innate immune response following multivalent dengue vaccination and implications for protection against dengue challenge. JCI Insight https://doi.org/10.1172/jci.insight.157811 (2022).
Nivarthi, U. K. et al. Longitudinal analysis of acute and convalescent B cell responses in a human primary dengue serotype 2 infection model. EBioMedicine 41, 465–478 (2019).
Article PubMed PubMed Central Google Scholar
Hanley, J. P. et al. Immunotranscriptomic profiling the acute and clearance phases of a human challenge dengue virus serotype 2 infection model. Nat. Commun. 12, 3054 (2021).
Article CAS PubMed PubMed Central Google Scholar
Sabin, A. B. Research on dengue during World War II. Am. J. Trop. Med. Hyg. 1, 30–50 (1952).
Article CAS PubMed Google Scholar
McCracken, M. K. et al. Route of inoculation and mosquito vector exposure modulate dengue virus replication kinetics and immune responses in rhesus macaques. PLoS Negl.Trop. Dis. 14, e0008191 (2020).
Article PubMed PubMed Central Google Scholar
Dengue 3 human infection model (DENV-3). ClinicalTrials.gov https://www.clinicaltrials.gov/study/NCT04298138 (2022).
Houng, H. S., Chung-Ming Chen, R., Vaughn, D. W. & Kanesa-thasan, N. Development of a fluorogenic RT–PCR system for quantitative identification of dengue virus serotypes 1–4 using conserved and serotype-specific 3′ noncoding sequences. J. Virol. Methods 95, 19–32 (2001).
Article CAS PubMed Google Scholar
Kraus, A. A., Messer, W., Haymore, L. B. & de Silva, A. M. Comparison of plaque- and flow cytometry-based methods for measuring dengue virus neutralization. J. Clin. Microbiol. 45, 3777–3780 (2007).
Article PubMed PubMed Central Google Scholar
de Alwis, R. et al. Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions. Proc. Natl Acad. Sci. USA 109, 7439–7444 (2012).
Article PubMed PubMed Central Google Scholar
Berry, A. S. F. et al. An open-source toolkit to expand bioinformatics training in infectious diseases. mBio 12, e0121421 (2021).
Bray, N. L., Pimentel, H., Melsted, P. & Pachter, L. Erratum: near-optimal probabilistic RNA-seq quantification. Nat. Biotechnol. 34, 888 (2016).
Article CAS PubMed Google Scholar
Soneson, C., Love, M. I. & Robinson, M. D. Differential analyses for RNA-seq: transcript-level estimates improve gene-level inferences. F1000Res 4, 1521 (2015).
Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139–140 (2010).
Article CAS PubMed Google Scholar
McCarthy, D. J., Chen, Y. & Smyth, G. K. Differential expression analysis of multifactor RNA-seq experiments with respect to biological variation. Nucleic Acids Res. 40, 4288–4297 (2012).
Comments (0)